Zobrazeno 1 - 10
of 51
pro vyhledávání: '"for the INTRO-HCV Study Group"'
Autor:
Karl Trygve Druckrey-Fiskaaen, Jørn Henrik Vold, Tesfaye Madebo, Håvard Midgard, Olav Dalgard, Rafael Alexander Leiva, Lars T. Fadnes, for the INTRO-HCV Study Group
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 19, Iss 1, Pp 1-11 (2024)
Abstract Background Persons with opioid use disorders (OUD) and persons with substance use disorders (SUD) who inject substances have a reduced life expectancy of up to 25 years compared with the general population. Chronic liver diseases are a subst
Externí odkaz:
https://doaj.org/article/d694804c641d46cd8db40f37ed00b3e0
Autor:
Jørn Henrik Vold, Rolf Gjestad, Christer F. Aas, Eivind Meland, Kjell Arne Johansson, Lars Thore Fadnes, for the INTRO-HCV Study Group
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background Little attention has been paid to customising fatigue questionnaires for patients with Substance Use Disorders (SUDs). The present study aims to validate and shorten the nine-item Fatigue Severity Scale (FSS-9) and Visual Analogue
Externí odkaz:
https://doaj.org/article/7e23d1f290864105b0a678ca73556d2a
Autor:
Christer Frode Aas, Jørn Henrik Vold, Rolf Gjestad, Svetlana Skurtveit, Aaron Guanliang Lim, Kristian Varden Gjerde, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes, for the INTRO-HCV Study Group
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 16, Iss 1, Pp 1-10 (2021)
Abstract Background There is high co-occurrence of substance use disorders (SUD) and mental health disorders. We aimed to assess impact of substance use patterns and sociodemographic factors on mental health distress using the ten-item Hopkins Sympto
Externí odkaz:
https://doaj.org/article/df416c6493f34a50999edbdc87723901
Autor:
Jørn Henrik Vold, Rolf Gjestad, Christer F. Aas, Fatemeh Chalabianloo, Svetlana Skurtveit, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes, for the INTRO-HCV Study Group
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 15, Iss 1, Pp 1-11 (2020)
Abstract Background The impact of clinical and sociodemographic factors on fatigue remains unknown among patients with substance use disorders (SUD). This study aims to evaluate fatigue among patients with SUD using a nine-item fatigue severity scale
Externí odkaz:
https://doaj.org/article/79c33c06cd8c423eb42b47bc6807d07f
Autor:
Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit, Aaron G. Lim, Sabine Ruths, Kamrul Islam, Jan Erik Askildsen, Else-Marie Løberg, Lars Thore Fadnes, Kjell Arne Johansson, for the INTRO-HCV Study Group
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 15, Iss 1, Pp 1-12 (2020)
Abstract Background Opioid dependence carries the highest disease burden of all illicit drugs. Opioid agonist therapy (OAT) is an evidence-based medical intervention that reduces morbidity and mortality. There is limited knowledge on the health-relat
Externí odkaz:
https://doaj.org/article/d66146d60d434dbcb2cfc56613603cd5
Autor:
Ole Jørgen Lygren, Ronny Bjørnestad, Else-Marie Løberg, Martine Lepsøy Bonnier, Vibeke Bråthen Buljovcic, Kjell Arne Johansson, Lars T. Fadnes, for the INTRO-HCV Study Group
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 14, Iss 1, Pp 1-7 (2019)
Abstract Background For people with opioid dependence in Norway, chronic hepatitis C virus (HCV) infections contribute to high mortality and high morbidity. Around 50% of patients in medically assisted rehabilitation (MAR) have been shown to have HCV
Externí odkaz:
https://doaj.org/article/5a16a4be7aba43afa5d5e2284d4bd3a6
Autor:
Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold, Rafael Alexander Leiva, Christian Ohldieck, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else-Marie Løberg, Kjell Arne Johansson, INTRO-HCV Study Group
Publikováno v:
PLoS Medicine, Vol 18, Iss 6, p e1003653 (2021)
BackgroundThe standard pathways of testing and treatment for hepatitis C virus (HCV) infection in tertiary healthcare are not easily accessed by people who inject drugs (PWID). The aim of this study was to evaluate the efficacy of integrated treatmen
Externí odkaz:
https://doaj.org/article/9bb6e6612a1840878acf19b5da6099cb
Autor:
Lars T. Fadnes, Christer Frode Aas, Jørn Henrik Vold, Christian Ohldieck, Rafael Alexander Leiva, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else-Marie Løberg, Kjell Arne Johansson, for the INTRO-HCV Study Group
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background A large proportion of people who inject drugs (PWID) living with hepatitis C virus (HCV) infection have not been treated. It is unknown whether inclusion of HCV diagnostics and treatment into integrated substance use disorder trea
Externí odkaz:
https://doaj.org/article/f93b58bba1bd4b6d945e93e634afac23
Autor:
Fadnes, Lars T., Aas, Christer Frode, Vold, Jørn Henrik, Leiva, Rafael Alexander, Ohldieck, Christian, Chalabianloo, Fatemeh, Skurtveit, Svetlana, Lygren, Ole Jørgen, Dalgård, Olav, Vickerman, Peter, Midgard, Håvard, Løberg, Else-Marie, Johansson, Kjell Arne, INTRO-HCV Study Group
Publikováno v:
PLoS Medicine; 6/1/2021, Vol. 18 Issue 6, p1-17, 17p, 1 Diagram, 2 Charts, 3 Graphs
Autor:
Vold, Jørn Henrik, Gjestad, Rolf, Aas, Christer F., Meland, Eivind, Johansson, Kjell Arne, Fadnes, Lars Thore, INTRO-HCV Study Group
Publikováno v:
Health & Quality of Life Outcomes; 3/2/2021, Vol. 19 Issue 1, p1-11, 11p